This inventor holds 1 USPTO granted patent and 13 published patent applications. Top assignee: Regenxbio Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Stephen Joseph Pakola
Introduction
Stephen Joseph Pakola is an accomplished inventor based in Irvington, NY (US). He has made significant contributions to the field of biotechnology, particularly in the treatment of rare genetic disorders. His work focuses on innovative methods to deliver therapeutic agents to patients in need.
Latest Patents
Stephen Pakola holds a patent for the treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS). This patent describes compositions and methods for delivering recombinant human iduronate-2-sulfatase produced by human neuronal or glial cells to the cerebrospinal fluid of the central nervous system (CNS) of individuals diagnosed with mucopolysaccharidosis II (MPS II). He has 1 patent to his name.
Career Highlights
Pakola is currently associated with Regenxbio Inc., a company known for its innovative gene therapy solutions. His work at Regenxbio has positioned him as a key player in the development of treatments for genetic disorders.
Collaborations
Some of his notable coworkers include Paulo Falabella and Marie-Laure Nevoret. Their collaborative efforts contribute to the advancement of research and development in the field of biotechnology.
Conclusion
Stephen Joseph Pakola's innovative work in the treatment of mucopolysaccharidosis II showcases his dedication to improving patient outcomes through biotechnology. His contributions are paving the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile